Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Urologic Oncology
|
January 3, 2016
Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes
Kelly L Stratton, Shaheen Alanee, Emily A Glogowski, et al.
Urologic Oncology
|
April 9, 2020
The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillance
Grace Yaguchi, Hoang J Tang, Mustafa Deebajah, et al.
Histopathology
|
April 5, 2018
Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements
Judith A S Jebastin, Steven C Smith, Kyle D Perry, et al.
World Journal of Urology
|
May 9, 2021
Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment
Shaheen Alanee, Sherjeel Sana, Ahmed El-Zawahry, et al.
Cancer Medicine
|
May 22, 2019
Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancer
Eric L Walton, Mustafa Deebajah, Jacob Keeley, et al.
World Journal of Urology
|
August 3, 2018
Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder
Shaheen Alanee, Isabel Alvarado-Cabrero, Paari Murugan, et al.
Cancers
|
July 29, 2025
[<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Progressive PSMA+ mCRPC Treated With or Without Prior Taxane-Based Chemotherapy: A Phase 2, Open-Label, Single-Arm Trial in Japan
Kouji Izumi, Ryuji Matsumoto, Yusuke Ito, et al.
Urologic Oncology
|
August 25, 2018
Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis
Philipp Gild, Stephanie A Wankowicz, Akshay Sood, et al.
European Urology
|
December 4, 2016
Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma
Thomas Seisen, Tarun Jindal, Patrick Karabon, et al.
Clinical Genitourinary Cancer
|
March 30, 2024
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment
Jazzmyne Montgomery, Daniel Lybbert, Sherjeel Sana, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Urologic Oncology
|
January 3, 2016
Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes
Kelly L Stratton, Shaheen Alanee, Emily A Glogowski, et al.
Urologic Oncology
|
April 9, 2020
The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillance
Grace Yaguchi, Hoang J Tang, Mustafa Deebajah, et al.
Histopathology
|
April 5, 2018
Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements
Judith A S Jebastin, Steven C Smith, Kyle D Perry, et al.
World Journal of Urology
|
May 9, 2021
Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment
Shaheen Alanee, Sherjeel Sana, Ahmed El-Zawahry, et al.
Cancer Medicine
|
May 22, 2019
Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancer
Eric L Walton, Mustafa Deebajah, Jacob Keeley, et al.
World Journal of Urology
|
August 3, 2018
Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder
Shaheen Alanee, Isabel Alvarado-Cabrero, Paari Murugan, et al.
Cancers
|
July 29, 2025
[<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Progressive PSMA+ mCRPC Treated With or Without Prior Taxane-Based Chemotherapy: A Phase 2, Open-Label, Single-Arm Trial in Japan
Kouji Izumi, Ryuji Matsumoto, Yusuke Ito, et al.
Urologic Oncology
|
August 25, 2018
Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis
Philipp Gild, Stephanie A Wankowicz, Akshay Sood, et al.
European Urology
|
December 4, 2016
Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma
Thomas Seisen, Tarun Jindal, Patrick Karabon, et al.
Clinical Genitourinary Cancer
|
March 30, 2024
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment
Jazzmyne Montgomery, Daniel Lybbert, Sherjeel Sana, et al.
Page
of 9